Key enzymes such as indoleamine 2,3-dioxygenase (IDO1) and tryptophan 2,3-dioxygenase (TDO2) are commonly overexpressed in human glioma cells, resulting in elevated production of kynurenine. This evidence concerns the gene IDO1 and central nervous system cancer.